The Neuroprotective Effects of MGlu1 Receptor Antagonists Are Mediated by an Enhancement of GABAergic Synaptic Transmission Via a Presynaptic CB1 Receptor Mechanism

Overview

Journal Cells

Publisher MDPI

Specialties Biochemistry
Biophysics
Cell Biology
Molecular Biology

Date 2022 Oct 14

PMID 36230976

Authors

Elisa Landucci

Rolando Berlinguer-Palmini

Gilda Baccini

Francesca Boscia

Elisabetta Gerace

Guido Mannaioni

Domenico E Pellegrini-Giampietro

Affiliations

Soon will be listed here.

Abstract

In this study, we investigated the cross-talk between mGlu1 and CB1 receptors in modulating GABA hippocampal output in whole-cell voltage clamp recordings in rat hippocampal acute slices, in organotypic hippocampal slices exposed to oxygen and glucose deprivation (OGD) and in gerbils subjected to global ischemia. CB1 receptor expression was studied using immunohistochemistry and the CA1 contents of anandamide (AEA) and 2-arachidonoylglycerol (2-AG) were measured by LC-MS/MS. Our results show that mGlu1 receptor antagonists enhance sIPSCs in CA1 pyramidal cells and the basal and ischemic hippocampal release of GABA in vivo in a manner that is mediated by CB1 receptor activation. In hippocampal slices exposed to OGD and in ischemic gerbils, mGlu1 receptor antagonists protected CA1 pyramidal cells against post-ischemic injury and this effect was reduced by CB1 receptor activation. OGD induced a transient increase in the hippocampal content of AEA and this effect is prevented by mGlu1 receptor antagonist. Finally, OGD induced a late disruption of CB1 receptors in the CA1 region and the effect was prevented when CA1 pyramidal cells were protected by mGlu1 antagonists. Altogether, these results suggest a cooperative interaction between mGlu1 receptors and the endocannabinoid system in the mechanisms that lead to post-ischemic neuronal death.

Citing Articles

Functional Interaction between Adenosine A and mGlu Receptors Mediates STEP Phosphatase Activation and Promotes STEP/mGluR Binding in Mouse Hippocampus and Neuroblastoma Cell Line.

Mallozzi C, Pepponi R, Gaddini L, Casella I, Chiodi V, Popoli P Biomolecules. 2023; 13(9).

PMID: 37759748 PMC: 10527457. DOI: 10.3390/biom13091350.

Targeting mGlu1 Receptors in the Treatment of Motor and Cognitive Dysfunctions in Mice Modeling Type 1 Spinocerebellar Ataxia.

Liberatore F, Antenucci N, Tortolani D, Mascio G, Fanti F, Sergi M Cells. 2022; 11(23).

PMID: 36497172 PMC: 9738505. DOI: 10.3390/cells11233916.

References

Cozzi A, Meli E, Carla V, Pellicciari R, Moroni F, Pellegrini-Giampietro D . Metabotropic glutamate 1 (mGlu1) receptor antagonists enhance GABAergic neurotransmission: a mechanism for the attenuation of post-ischemic injury and epileptiform activity?. Neuropharmacology. 2002; 43(2):119-30. DOI: 10.1016/s0028-3908(02)00080-1. View

Schwartz-Bloom R, Miller K, Evenson D, Crain B, Nadler J . Benzodiazepines protect hippocampal neurons from degeneration after transient cerebral ischemia: an ultrastructural study. Neuroscience. 2000; 98(3):471-84. DOI: 10.1016/s0306-4522(00)00144-5. View

Berthele A, Laurie D, Platzer S, Zieglgansberger W, Tolle T, Sommer B . Differential expression of rat and human type I metabotropic glutamate receptor splice variant messenger RNAs. Neuroscience. 1998; 85(3):733-49. DOI: 10.1016/s0306-4522(97)00670-2. View

Cavallo D, Landucci E, Gerace E, Lana D, Ugolini F, Henley J . Neuroprotective effects of mGluR5 activation through the PI3K/Akt pathway and the molecular switch of AMPA receptors. Neuropharmacology. 2019; 162:107810. DOI: 10.1016/j.neuropharm.2019.107810. View

Cozzi N, Nichols D . 5-HT2A receptor antagonists inhibit potassium-stimulated gamma-aminobutyric acid release in rat frontal cortex. Eur J Pharmacol. 1996; 309(1):25-31. DOI: 10.1016/0014-2999(96)00325-1. View

Nakanishi S . Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron. 1994; 13(5):1031-7. DOI: 10.1016/0896-6273(94)90043-4. View

Chen K, Neu A, Howard A, Foldy C, Echegoyen J, Hilgenberg L . Prevention of plasticity of endocannabinoid signaling inhibits persistent limbic hyperexcitability caused by developmental seizures. J Neurosci. 2007; 27(1):46-58. PMC: 6672287. DOI: 10.1523/JNEUROSCI.3966-06.2007. View

Bruno V, Copani A, Knopfel T, Kuhn R, Casabona G, DellAlbani P . Activation of metabotropic glutamate receptors coupled to inositol phospholipid hydrolysis amplifies NMDA-induced neuronal degeneration in cultured cortical cells. Neuropharmacology. 1995; 34(8):1089-98. DOI: 10.1016/0028-3908(95)00077-j. View

Moroni F, Attucci S, Cozzi A, Meli E, Picca R, Scheideler M . The novel and systemically active metabotropic glutamate 1 (mGlu1) receptor antagonist 3-MATIDA reduces post-ischemic neuronal death. Neuropharmacology. 2002; 42(6):741-51. DOI: 10.1016/s0028-3908(02)00033-3. View

10.

Wilson R, Nicoll R . Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature. 2001; 410(6828):588-92. DOI: 10.1038/35069076. View

11.

Pellegrini-Giampietro D, Cozzi A, Moroni F . The glycine antagonist and free radical scavenger 7-Cl-thio-kynurenate reduces CA1 ischemic damage in the gerbil. Neuroscience. 1994; 63(3):701-9. DOI: 10.1016/0306-4522(94)90516-9. View

12.

Bushell T, Lee C, Shigemoto R, Miller R . Modulation of synaptic transmission and differential localisation of mGlus in cultured hippocampal autapses. Neuropharmacology. 1999; 38(10):1553-67. DOI: 10.1016/s0028-3908(99)00103-3. View

13.

Gereau 4th R, Conn P . Roles of specific metabotropic glutamate receptor subtypes in regulation of hippocampal CA1 pyramidal cell excitability. J Neurophysiol. 1995; 74(1):122-9. DOI: 10.1152/jn.1995.74.1.122. View

14.

Losonczy A, Biro A, Nusser Z . Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci U S A. 2004; 101(5):1362-7. PMC: 337058. DOI: 10.1073/pnas.0304752101. View

15.

Boscia F, Ferraguti F, Moroni F, Annunziato L, Pellegrini-Giampietro D . mGlu1alpha receptors are co-expressed with CB1 receptors in a subset of interneurons in the CA1 region of organotypic hippocampal slice cultures and adult rat brain. Neuropharmacology. 2008; 55(4):428-39. DOI: 10.1016/j.neuropharm.2008.04.024. View

16.

Honore E, Khlaifia A, Bosson A, Lacaille J . Hippocampal Somatostatin Interneurons, Long-Term Synaptic Plasticity and Memory. Front Neural Circuits. 2021; 15:687558. PMC: 8206813. DOI: 10.3389/fncir.2021.687558. View

17.

Schwartz R, Yu X, Katzman M, Hayden-Hixson D, Perry J . Diazepam, given postischemia, protects selectively vulnerable neurons in the rat hippocampus and striatum. J Neurosci. 1995; 15(1 Pt 2):529-39. PMC: 6578265. View

18.

Pellegrini-Giampietro D, CHERICI G, Alesiani M, Carla V, Moroni F . Excitatory amino acid release and free radical formation may cooperate in the genesis of ischemia-induced neuronal damage. J Neurosci. 1990; 10(3):1035-41. PMC: 6570140. View

19.

Xiang Z, Lv X, Maksymetz J, Stansley B, Ghoshal A, Gogliotti R . mGlu Positive Allosteric Modulators Facilitate Long-Term Potentiation via Disinhibition Mediated by mGlu-Endocannabinoid Signaling. ACS Pharmacol Transl Sci. 2019; 2(3):198-209. PMC: 6591772. DOI: 10.1021/acsptsci.9b00017. View

20.

Battaglia G, Bruno V, Pisani A, Centonze D, Catania M, Calabresi P . Selective blockade of type-1 metabotropic glutamate receptors induces neuroprotection by enhancing gabaergic transmission. Mol Cell Neurosci. 2001; 17(6):1071-83. DOI: 10.1006/mcne.2001.0992. View